Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00329706 · ClinicalTrials.gov registry record · NA
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 710
- Enrollment target
NCT00329706 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 710 participants.
The verdict
NCT00329706, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 710 participants
- Enrollment target
Study Summary
A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" (Centers for Medicare and Medicaid Services, Decision Memo CAG-00088R, 2004), but evidence is less clear for patients having less severe cognitive problems. A substantial portion of such patients will develop Alzheimer's disease and other forms of dementia, which affect millions of people in the U.S., costing us over $100 billion annually. This project employs a prospective randomized protocol to determine whether PET scanning can help distinguish those patients with early Alzheimer's changes in their brains from those having other causes of cognitive impairment more accurately than is done with current clinical practices alone, and lead to earlier, more effective therapies which extend patients' abilities to think and function independently.
Interventions
- PROCEDURE FDG-PET brain scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 710 participants |
| Start Date | 2006-06 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00329706
The ClinicalTrials.gov registry entry for NCT00329706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 710 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG-PET brain scan is the first listed.
NCT00329706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00329706 about?
NCT00329706 is a clinical study titled "Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)". A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" (Centers for Medicare and Medicaid Services, Decision Memo CAG-00088R, 2004), but evidence is less clear for patients having less severe cognitive problems. A substantia...
What is the current status of trial NCT00329706?
This trial is currently completed. It is a NA study. The enrollment target is 710 participants. The study started on 2006-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT00329706?
The interventions under investigation include: FDG-PET brain scan (PROCEDURE).
Who is sponsoring clinical trial NCT00329706?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.